Is muscle and protein loss relevant in long-term fasting in healthy men? A prospective trial on physiological adaptations.
Apelin
Body composition
Energy metabolism
Lipids
Long-term fasting
Muscle function
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
23
06
2021
received:
16
11
2020
accepted:
10
07
2021
pubmed:
21
10
2021
medline:
29
1
2022
entrez:
20
10
2021
Statut:
ppublish
Résumé
Fasting is attracting an increasing interest as a potential strategy for managing diseases, including metabolic disorders and complementary cancer therapy. Despite concerns of clinicians regarding protein catabolism and muscle loss, evidence-based clinical data in response to long-term fasting in healthy humans are scarce. The objective of this study was to measure clinical constants, metabolic, and muscular response in healthy men during and after a 10 day fast combined with a physical activity programme. Sixteen men (44 ± 14 years; 26.2 ± 0.9 kg/m The 10 day fast decreased BW by 7% (-5.9 ± 0.2 kg, P < 0.001) and BMR by 12% (P < 0.01). Fat mass and lean soft tissues (LST) accounted for about 40% and 60% of weight loss, respectively, -2.3 ± 0.18 kg and -3.53 ± 0.13 kg, P < 0.001. LST loss was explained by the reduction in extracellular water (44%), muscle and liver glycogen and associated water (14%), and metabolic active lean tissue (42%). Plasma 3-methyl-histidine increased until Day 5 of fasting and then decreased, suggesting that protein sparing might follow early proteolysis. Daily steps count increased by 60% (P < 0.001) during the fasting period. Strength was maintained in non-weight-bearing muscles and increased in weight-bearing muscles (+33%, P < 0.001). Glycaemia, insulinemia, blood lipids, and blood pressure dropped during the fast (P < 0.05 for all), while non-esterified fatty acids and urinary beta-hydroxybutyrate increased (P < 0.01 for both). After a transient reduction, inflammatory cytokines returned to baseline at Day 10 of fasting, and LST were still lower than baseline values (-2.3% and -3.2%, respectively; P < 0.05 for both). A 10 day fast appears safe in healthy humans. Protein loss occurs in early fast but decreases as ketogenesis increases. Fasting combined with physical activity does not negatively impact muscle function. Future studies will need to confirm these first findings.
Sections du résumé
BACKGROUND
Fasting is attracting an increasing interest as a potential strategy for managing diseases, including metabolic disorders and complementary cancer therapy. Despite concerns of clinicians regarding protein catabolism and muscle loss, evidence-based clinical data in response to long-term fasting in healthy humans are scarce. The objective of this study was to measure clinical constants, metabolic, and muscular response in healthy men during and after a 10 day fast combined with a physical activity programme.
METHODS
Sixteen men (44 ± 14 years; 26.2 ± 0.9 kg/m
RESULTS
The 10 day fast decreased BW by 7% (-5.9 ± 0.2 kg, P < 0.001) and BMR by 12% (P < 0.01). Fat mass and lean soft tissues (LST) accounted for about 40% and 60% of weight loss, respectively, -2.3 ± 0.18 kg and -3.53 ± 0.13 kg, P < 0.001. LST loss was explained by the reduction in extracellular water (44%), muscle and liver glycogen and associated water (14%), and metabolic active lean tissue (42%). Plasma 3-methyl-histidine increased until Day 5 of fasting and then decreased, suggesting that protein sparing might follow early proteolysis. Daily steps count increased by 60% (P < 0.001) during the fasting period. Strength was maintained in non-weight-bearing muscles and increased in weight-bearing muscles (+33%, P < 0.001). Glycaemia, insulinemia, blood lipids, and blood pressure dropped during the fast (P < 0.05 for all), while non-esterified fatty acids and urinary beta-hydroxybutyrate increased (P < 0.01 for both). After a transient reduction, inflammatory cytokines returned to baseline at Day 10 of fasting, and LST were still lower than baseline values (-2.3% and -3.2%, respectively; P < 0.05 for both).
CONCLUSIONS
A 10 day fast appears safe in healthy humans. Protein loss occurs in early fast but decreases as ketogenesis increases. Fasting combined with physical activity does not negatively impact muscle function. Future studies will need to confirm these first findings.
Identifiants
pubmed: 34668663
doi: 10.1002/jcsm.12766
pmc: PMC8718030
doi:
Banques de données
DRKS
['DRKS00011165']
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1690-1703Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK048520
Pays : United States
Informations de copyright
© 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
Internist (Berl). 1970 May;11(5):176-83
pubmed: 4939022
Diabetes. 2012 Feb;61(2):310-20
pubmed: 22210322
Am J Clin Nutr. 1979 Aug;32(8):1570-4
pubmed: 463798
Cell Metab. 2020 Jan 7;31(1):92-104.e5
pubmed: 31813824
Ann Med. 2020 Aug;52(5):147-161
pubmed: 32519900
N Engl J Med. 1970 Mar 19;282(12):668-75
pubmed: 4915800
Cell Metab. 2014 Feb 4;19(2):181-92
pubmed: 24440038
Int J Endocrinol. 2015;2015:508409
pubmed: 26136779
Am J Clin Nutr. 2017 Apr;105(4):913-927
pubmed: 28228420
Int J Obes (Lond). 2015 May;39(5):727-33
pubmed: 25540982
Exp Clin Endocrinol Diabetes. 2017 Oct;125(9):618-624
pubmed: 28407662
Am J Clin Nutr. 1998 Jul;68(1):12-34
pubmed: 9665093
Lancet. 1969 May 3;1(7601):914-6
pubmed: 4180896
N Engl J Med. 1997 Oct 2;337(14):986-94
pubmed: 9309105
Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E923-30
pubmed: 11882514
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145
pubmed: 31661195
Am J Clin Nutr. 2000 Jun;71(6):1511-5
pubmed: 10837292
JAMA Intern Med. 2017 Jul 1;177(7):930-938
pubmed: 28459931
Proteomics. 2014 Aug;14(16):1905-21
pubmed: 24920225
Stress. 2016;19(2):151-7
pubmed: 26586092
J Clin Invest. 2015 Nov 03;125(12):4592-600
pubmed: 26529255
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1690-1703
pubmed: 34668663
J Appl Physiol (1985). 2018 Mar 1;124(3):780-790
pubmed: 29191980
PLoS One. 2019 Jan 2;14(1):e0209353
pubmed: 30601864
Food Chem Toxicol. 2020 Nov;145:111701
pubmed: 32858131
Aging (Albany NY). 2016 Jul;8(7):1416-31
pubmed: 27410480
J Am Heart Assoc. 2020 Dec;9(23):e018649
pubmed: 33222606
Am J Clin Nutr. 2019 Sep 1;110(3):628-640
pubmed: 31268131
N Engl J Med. 2019 Dec 26;381(26):2541-2551
pubmed: 31881139
J Appl Physiol (1985). 2015 Mar 15;118(6):716-22
pubmed: 25593289
Free Radic Biol Med. 2007 Mar 1;42(5):665-74
pubmed: 17291990
Clin Nutr. 2016 Dec;35(6):1557-1563
pubmed: 26922142
Postgrad Med J. 1973 Mar;49(569):203-9
pubmed: 4803438
Int J Obes. 1981;5(3):243-8
pubmed: 7275462
Int J Behav Nutr Phys Act. 2016 Nov 3;13(1):113
pubmed: 27809874
J Clin Invest. 1970 Dec;49(12):2256-70
pubmed: 5480852
Am J Clin Nutr. 2000 Aug;72(2):355-60
pubmed: 10919927
Scand J Clin Lab Invest. 1973 Dec;32(4):325-30
pubmed: 4771102
Forsch Komplementmed. 2013;20(6):434-43
pubmed: 24434758